Vectorite Biomedical Inc. (TPEX:4170)
Taiwan
· Delayed Price · Currency is TWD 13.75
-0.05 (-0.36%)
Apr 29, 2026, 1:57 PM CST
Vectorite Biomedical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 96.14 | -40.05 | -6.6 | -26.41 | 8.36 | Upgrade
|
| Depreciation & Amortization | 8.14 | 8.76 | 9.16 | 8.86 | 16.49 | Upgrade
|
| Other Amortization | - | - | - | - | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.63 | 15.77 | 0.73 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -119.04 | 6.4 | -3.88 | 0.98 | -51.05 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | 5.84 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 0.02 | Upgrade
|
| Other Operating Activities | - | -0.02 | -0.03 | -0.04 | -0.02 | Upgrade
|
| Change in Accounts Receivable | 3.34 | -0.47 | -0.05 | -4.48 | 1.17 | Upgrade
|
| Change in Inventory | -0.18 | -4.75 | -5.21 | 2.41 | -1.92 | Upgrade
|
| Change in Accounts Payable | -0.22 | -0.06 | -1.98 | 0.47 | 1.06 | Upgrade
|
| Change in Unearned Revenue | -0.88 | 1.83 | -2.53 | -0.81 | 2.66 | Upgrade
|
| Change in Other Net Operating Assets | 1.34 | 1.1 | 5.62 | -6.42 | -2.82 | Upgrade
|
| Operating Cash Flow | -5.79 | -11.51 | 1.3 | 14.7 | -65.79 | Upgrade
|
| Operating Cash Flow Growth | - | - | -91.17% | - | - | Upgrade
|
| Capital Expenditures | -4 | -2.84 | -4.76 | -0.89 | -1.8 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | - | - | - | - | Upgrade
|
| Investment in Securities | 5.62 | 24.08 | 1.33 | -25.2 | -39.88 | Upgrade
|
| Other Investing Activities | -0.32 | -4.87 | -0.4 | -0.25 | 0.01 | Upgrade
|
| Investing Cash Flow | 1.35 | 16.36 | -3.82 | -26.34 | -41.67 | Upgrade
|
| Long-Term Debt Repaid | -0.14 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -0.14 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.14 | - | - | - | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 118.08 | Upgrade
|
| Other Financing Activities | -0.2 | 0.2 | - | - | - | Upgrade
|
| Financing Cash Flow | -0.34 | 0.2 | - | - | 118.08 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.11 | 0.23 | -0.04 | 0.32 | -0.18 | Upgrade
|
| Net Cash Flow | -4.89 | 5.29 | -2.56 | -11.32 | 10.44 | Upgrade
|
| Free Cash Flow | -9.78 | -14.35 | -3.46 | 13.81 | -67.59 | Upgrade
|
| Free Cash Flow Margin | -15.93% | -24.84% | -6.19% | 32.19% | -234.93% | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -0.33 | -0.08 | 0.32 | -1.57 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | -0.01 | Upgrade
|
| Levered Free Cash Flow | -5.91 | -12.32 | -9.41 | -19.78 | -11.42 | Upgrade
|
| Unlevered Free Cash Flow | -5.9 | -12.32 | -9.41 | -19.78 | -11.42 | Upgrade
|
| Change in Working Capital | 3.39 | -2.36 | 1.92 | 31.32 | -45.45 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.